Pan-retinal scatter photocoagulation (PRP) is the established treatment in patients with PDR (1, 2), but sometimes brings decreased visual acuity due to PRP-induced macular edema (3, 4, 16-18) which could be related with vitreous cytokines including VEGF and IL-6 (9). Here, VEGFA is linked to macular retinal edema.